Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices
Abstract Background Cyclophosphamide (CYC) is an inactive alkylating agent that transforms the alkyl radicals into other molecules and is used in combination with systemic corticosteroids in the treatment of many childhood rheumatic diseases, such as systemic lupus erythematosus (SLE), and ANCA-asso...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2025-03-01
|
| סדרה: | Pediatric Rheumatology Online Journal |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12969-025-01080-9 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
